After fluvastatin therapy, functional capacity and LVEF improved and the levels of TNF-α and IL-6 decreased. The results revealed fluvastatin improved cardiac functions and the clinical symptoms in HF patients with either idiopathic dilated or ischemic etiology. This evidence concerns the gene TNF and hydrops fetalis.